Benzimidazole and other fused ring derivatives as selective janus kinase inhibitors
Disclosed is a compound of formula I, or a pharmaceutically acceptable prodrug, salt, hydrate, solvate, crystal form, or diastereoisomer thereof, wherein up to one of X1 to X4 may be nitrogen, and the others are substituted carbon, A is a substituted pyridine, pyrazine, pyrimidine, or 1,3,5-triazine...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WILKS, ANDREW FREDERICK TREUTLEIN, HERBERT RUDOLF BU, XIANYONG STYLES, MICHELLE LEANNE BURNS, CHRISTOPHER ZENG, JUN KLING, MARCEL ROBERT |
| description | Disclosed is a compound of formula I, or a pharmaceutically acceptable prodrug, salt, hydrate, solvate, crystal form, or diastereoisomer thereof, wherein up to one of X1 to X4 may be nitrogen, and the others are substituted carbon, A is a substituted pyridine, pyrazine, pyrimidine, or 1,3,5-triazine, Q is a bond, C1-4alkyl, O, S, SO, SO2, CO, or CS, and wherein the other substituents are as defined in the specification. Also disclosed is the use of the compound for inhibiting JAK-3, and for treating diseases such as atopy, allergic asthma, atopic dermatitis, allergic rhinitis, cell mediated hypersensitivity, rheumatic diseases, transplant rejection, graft versus host disease, viral diseases, proliferative diseases and cancer. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ546058A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ546058A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ546058A3</originalsourceid><addsrcrecordid>eNqFyjEKwkAQRuE0FqJeQeYCgqARWxXFykYrmzBm_ySj62zY2aTI6UWwt3p88MbZdQ8d5C2Oh-BBrI5CahCp6gyOomhNDlF6TtLDiI0MHuVX9GTtjF6ibCDRRh6SQrRpNqrYG2a_TrL56Xg7nBdoQwFruYQiFZd7vt4s8-1u9Xf4AFMgN_g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Benzimidazole and other fused ring derivatives as selective janus kinase inhibitors</title><source>esp@cenet</source><creator>WILKS, ANDREW FREDERICK ; TREUTLEIN, HERBERT RUDOLF ; BU, XIANYONG ; STYLES, MICHELLE LEANNE ; BURNS, CHRISTOPHER ; ZENG, JUN ; KLING, MARCEL ROBERT</creator><creatorcontrib>WILKS, ANDREW FREDERICK ; TREUTLEIN, HERBERT RUDOLF ; BU, XIANYONG ; STYLES, MICHELLE LEANNE ; BURNS, CHRISTOPHER ; ZENG, JUN ; KLING, MARCEL ROBERT</creatorcontrib><description>Disclosed is a compound of formula I, or a pharmaceutically acceptable prodrug, salt, hydrate, solvate, crystal form, or diastereoisomer thereof, wherein up to one of X1 to X4 may be nitrogen, and the others are substituted carbon, A is a substituted pyridine, pyrazine, pyrimidine, or 1,3,5-triazine, Q is a bond, C1-4alkyl, O, S, SO, SO2, CO, or CS, and wherein the other substituents are as defined in the specification. Also disclosed is the use of the compound for inhibiting JAK-3, and for treating diseases such as atopy, allergic asthma, atopic dermatitis, allergic rhinitis, cell mediated hypersensitivity, rheumatic diseases, transplant rejection, graft versus host disease, viral diseases, proliferative diseases and cancer.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100930&DB=EPODOC&CC=NZ&NR=546058A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25551,76302</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100930&DB=EPODOC&CC=NZ&NR=546058A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WILKS, ANDREW FREDERICK</creatorcontrib><creatorcontrib>TREUTLEIN, HERBERT RUDOLF</creatorcontrib><creatorcontrib>BU, XIANYONG</creatorcontrib><creatorcontrib>STYLES, MICHELLE LEANNE</creatorcontrib><creatorcontrib>BURNS, CHRISTOPHER</creatorcontrib><creatorcontrib>ZENG, JUN</creatorcontrib><creatorcontrib>KLING, MARCEL ROBERT</creatorcontrib><title>Benzimidazole and other fused ring derivatives as selective janus kinase inhibitors</title><description>Disclosed is a compound of formula I, or a pharmaceutically acceptable prodrug, salt, hydrate, solvate, crystal form, or diastereoisomer thereof, wherein up to one of X1 to X4 may be nitrogen, and the others are substituted carbon, A is a substituted pyridine, pyrazine, pyrimidine, or 1,3,5-triazine, Q is a bond, C1-4alkyl, O, S, SO, SO2, CO, or CS, and wherein the other substituents are as defined in the specification. Also disclosed is the use of the compound for inhibiting JAK-3, and for treating diseases such as atopy, allergic asthma, atopic dermatitis, allergic rhinitis, cell mediated hypersensitivity, rheumatic diseases, transplant rejection, graft versus host disease, viral diseases, proliferative diseases and cancer.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFyjEKwkAQRuE0FqJeQeYCgqARWxXFykYrmzBm_ySj62zY2aTI6UWwt3p88MbZdQ8d5C2Oh-BBrI5CahCp6gyOomhNDlF6TtLDiI0MHuVX9GTtjF6ibCDRRh6SQrRpNqrYG2a_TrL56Xg7nBdoQwFruYQiFZd7vt4s8-1u9Xf4AFMgN_g</recordid><startdate>20100930</startdate><enddate>20100930</enddate><creator>WILKS, ANDREW FREDERICK</creator><creator>TREUTLEIN, HERBERT RUDOLF</creator><creator>BU, XIANYONG</creator><creator>STYLES, MICHELLE LEANNE</creator><creator>BURNS, CHRISTOPHER</creator><creator>ZENG, JUN</creator><creator>KLING, MARCEL ROBERT</creator><scope>EVB</scope></search><sort><creationdate>20100930</creationdate><title>Benzimidazole and other fused ring derivatives as selective janus kinase inhibitors</title><author>WILKS, ANDREW FREDERICK ; TREUTLEIN, HERBERT RUDOLF ; BU, XIANYONG ; STYLES, MICHELLE LEANNE ; BURNS, CHRISTOPHER ; ZENG, JUN ; KLING, MARCEL ROBERT</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ546058A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WILKS, ANDREW FREDERICK</creatorcontrib><creatorcontrib>TREUTLEIN, HERBERT RUDOLF</creatorcontrib><creatorcontrib>BU, XIANYONG</creatorcontrib><creatorcontrib>STYLES, MICHELLE LEANNE</creatorcontrib><creatorcontrib>BURNS, CHRISTOPHER</creatorcontrib><creatorcontrib>ZENG, JUN</creatorcontrib><creatorcontrib>KLING, MARCEL ROBERT</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WILKS, ANDREW FREDERICK</au><au>TREUTLEIN, HERBERT RUDOLF</au><au>BU, XIANYONG</au><au>STYLES, MICHELLE LEANNE</au><au>BURNS, CHRISTOPHER</au><au>ZENG, JUN</au><au>KLING, MARCEL ROBERT</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Benzimidazole and other fused ring derivatives as selective janus kinase inhibitors</title><date>2010-09-30</date><risdate>2010</risdate><abstract>Disclosed is a compound of formula I, or a pharmaceutically acceptable prodrug, salt, hydrate, solvate, crystal form, or diastereoisomer thereof, wherein up to one of X1 to X4 may be nitrogen, and the others are substituted carbon, A is a substituted pyridine, pyrazine, pyrimidine, or 1,3,5-triazine, Q is a bond, C1-4alkyl, O, S, SO, SO2, CO, or CS, and wherein the other substituents are as defined in the specification. Also disclosed is the use of the compound for inhibiting JAK-3, and for treating diseases such as atopy, allergic asthma, atopic dermatitis, allergic rhinitis, cell mediated hypersensitivity, rheumatic diseases, transplant rejection, graft versus host disease, viral diseases, proliferative diseases and cancer.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_NZ546058A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Benzimidazole and other fused ring derivatives as selective janus kinase inhibitors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T20%3A24%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WILKS,%20ANDREW%20FREDERICK&rft.date=2010-09-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ546058A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |